NDC 85237-1868-01 - Excedrin Extra Strength Headache
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85237-1868
- Requested NDC
- 85237-1868-01
- Package NDCs from labels
- 85237-1868-1, 85237-1868-2, 85237-1868-3, 85237-1868-6, 85237-1868-01
- Manufacturer
- Select Consumer Group
- Effective date
- 2025-12-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Excedrin Extra Strength Headache - Select Consumer Group | Select Consumer Group | 2025-12-27 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85237-1868-1 | ExcedrinExtra Strength Headache | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 3 | |
| 85237-1868-1 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-2 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-2 | ExcedrinExtra Strength Headache | 2 in 1 BLISTER PACK | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-3 | ExcedrinExtra Strength Headache | 25 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 25 | 3 | |
| 85237-1868-3 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-6 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-6 | ExcedrinExtra Strength Headache | 50 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 50 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Robitussin Maximum Strength Severe Multi-Symptom Cough Cold Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Haleon US Holdings LLC | a6f750c8-8738-4965-a3ad-612c24611056 | 2025-11-18 | Warnings | 362O9ITL9D |
| YINCHIAO | ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE | ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD. | 09ba45f6-03e1-46b9-83ab-a618b2626716 | 2025-11-18 | Warnings | 362O9ITL9D |
| GANMAOLING | ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE | ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD. | c757a03e-59ea-469c-970d-4bc62e73f36f | 2025-11-18 | Warnings | 362O9ITL9D |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 17N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c48c66-bd5b-0024-e063-6394a90a6c7b | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 19C | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c512da-e4b6-dd9c-e063-6294a90a1730 | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 21N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c52258-2549-c42b-e063-6394a90a1526 | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 21W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c59de6-8eb2-d00a-e063-6294a90a0b04 | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 24W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c5bd02-62e0-019a-e063-6294a90adcf3 | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 23W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c5d54e-119c-0c6d-e063-6394a90aba4c | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 25N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c5eb1c-b268-acfb-e063-6394a90ad4cc | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 27C | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c6157a-4b62-8279-e063-6294a90abe05 | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 27W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c6252f-56b8-9e3c-e063-6294a90aa12c | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 28N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c62e80-9ace-c1f2-e063-6294a90a5bfa | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 29W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c6864c-bc8e-e900-e063-6294a90a7a14 | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 31N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c77b48-18fb-3efe-e063-6294a90ade4b | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 33N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c784ce-3a54-5416-e063-6294a90ac9a2 | 2025-11-17 | Warnings | 15FIX9V2JP |
| MIDOL COMPLETE | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | R J General Corporation | 0c09a178-1a07-4079-b4a6-d1657cb8e714 | 2025-11-17 | Warnings | M013 3G6A5W338E 362O9ITL9D |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | R J General Corporation | dbb0d067-71f0-45e4-bc98-548cf4a90b3a | 2025-11-17 | Warnings | M013 R16CO5Y76E |
| Alka-Seltzer Plus Severe Cold and Flu PowerFast Fizz | CHLORPHENIRAMINE MALEATE, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE | R J General Corporation | d786ae07-ce57-44c7-9ba5-f4c87df115de | 2025-11-17 | Warnings | 362O9ITL9D |
| TYLENOL COLD AND FLU | ACETAMINPHEN | R J General Corporation | b618877b-9dbc-4ba2-be2c-bf1922c646cc | 2025-11-17 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.